Alison L. Allan
Western University
H-index: 39
North America-Canada
Top articles of Alison L. Allan
Title | Journal | Author(s) | Publication Date |
|---|---|---|---|
Centrosomes and associated proteins in pathogenesis and treatment of breast cancer | Harjot Athwal Arpitha Kochiyanil Vasudeva Bhat Alison L Allan Armen Parsyan | 2024/3/28 | |
Detection of Circulating Tumor DNA After Stereotactic Ablative Radiotherapy in Patients With Unbiopsied Lung Tumors (SABR-DETECT) | Clinical Lung Cancer | Saurav Verma Sympascho Young Thomas AC Kennedy Ilda Carvalhana Morgan Black | 2024/3/1 |
PLK4 as a potential target to enhance radiosensitivity in triple-negative breast cancer | Radiation Oncology | Sierra Pellizzari Vasudeva Bhat Harjot Athwal David W Cescon Alison L Allan | 2024/2/16 |
Lung-derived soluble factors support stemness/plasticity and metastatic behaviour of breast cancer cells via the FGF2-DACH1 axis | Vasudeva Bhat Matthew Piaseczny David Goodale Ashkan Sadri Urvi Patel | 2023/10/17 | |
Influence of Extracellular Vesicles on Lung Stromal Cells during Breast Cancer Metastasis | Urvi Patel David Susman Alison L Allan | 2023/7/22 | |
Importance of Incorporating the Perspectives of People with Cancer into Oncology Education: A Scoping Review | Hanna Dutt Arleigh Dean Rayyan Syed Kamal Alison L Allan | 2023/12 | |
Involvement of the AKT Pathway in Resistance to Erlotinib and Cabozantinib in Triple-Negative Breast Cancer Cell Lines | Biomedicines | Cory Lefebvre Sierra Pellizzari Vasudeva Bhat Kristina Jurcic David W Litchfield | 2023/8/28 |
Circulating tumor cells detected in follow-up predict survival outcomes in tri-modality management of advanced non-metastatic esophageal cancer: a secondary analysis of the … | BMC cancer | Edward Yu Alison L Allan Michael Sanatani Debra Lewis Andrew Warner | 2022/7/8 |
Exploitation of treatment induced tumor lysis to enhance the sensitivity of ctDNA analysis: A first-in-human pilot study | Lung Cancer | Daniel A Breadner Mark D Vincent Rohann Correa Morgan Black Andrew Warner | 2022/3/1 |
Radiotherapy and radiosensitization in breast cancer: Molecular targets and clinical applications | Vasudeva Bhat Sierra Pellizzari Alison L Allan Eugene Wong Michael Lock | 2022/1/1 | |
Anti-proliferative and anti-migratory effects of EGFR and c-Met tyrosine kinase inhibitors in triple negative breast cancer cells | Precision Cancer Medicine | Cory Lefebvre Alison L Allan | 2021/3/30 |
A survivin-driven, tumor-activatable minicircle system for prostate cancer theranostics | Molecular Therapy-Oncolytics | TianDuo Wang Yuanxin Chen David Goodale Alison L Allan John A Ronald | 2021/3/26 |
EMT-independent detection of circulating tumor cells in human blood samples and pre-clinical mouse models of metastasis | Clinical & Experimental Metastasis | Jenna Kitz David Goodale Carl Postenka Lori E Lowes Alison L Allan | 2021/2 |
Reduced Zeb1 Expression in Prostate Cancer Cells Leads to an Aggressive Partial-EMT Phenotype Associated with Altered Global Methylation Patterns | International Journal of Molecular Sciences | Jenna Kitz Cory Lefebvre Joselia Carlos Lori E Lowes Alison L Allan | 2021/11/27 |
Lung-derived selectins enhance metastatic behavior of triple negative breast cancer cells | Biomedicines | Sami U Khan Ying Xia David Goodale Gabriella Schoettle Alison L Allan | 2021/10/30 |
Isolation and Functional Assessment of Human Breast Cancer Stem Cells from Cell and Tissue Samples | Journal of Visualized Experiments: Jove | Vasudeva Bhat Cory Lefebvre David Goodale Mauricio Rodriguez-Torres Alison L Allan | 2020/10/2 |
Abstract P4-01-12: The association of circulating tumor cells with tumor response in breast cancer patients undergoing neoadjuvant chemotherapy | Cancer Research | Jacques Raphael Reza Mohamadi Alex Kiss Maureen Trudeau Sunil Verma | 2020/2/15 |
Triple-negative primary breast tumors induce supportive premetastatic changes in the extracellular matrix and soluble components of the lung microenvironment | Cancers | Braeden Medeiros David Goodale Carl Postenka Lori E Lowes Patti Kiser | 2020/1/10 |
Stereotactic ablative radiotherapy for the comprehensive treatment of 1–3 Oligometastatic tumors (SABR-COMET-3): study protocol for a randomized phase III trial | Journal of Clinical Oncology | David A Palma Robert Olson Stephen Harrow Stewart Gaede Alexander V Louie | 2020/9/9 |
Everolimus in advanced breast cancer: a systematic review and meta-analysis | Jacques Raphael Cory Lefebvre Alison Allan Joelle Helou Gabriel Boldt | 2020/11/5 |
Co-Authors
